Dr Milan Vu
| Name | Dr Milan Vu |
|---|---|
| Job title | Technical Tutor (Bioscience) |
| Research institute | |
| Primary appointment | Science & Engineering Labs |
| Email address | M.Vu@mdx.ac.uk |
| ORCID | https://orcid.org/0000-0002-6851-7634 |
| Contact category | Researcher |
Biography
Biography Role: Technical Tutor in
Bioscience Technical
and Teaching responsibilities in Academia (Higher Education). Technical responsibility for Cancer and Biophysics Laboratory (H220). Middlesex
University, Department
of Natural Sciences, Faculty of Science & Technology, The
Burroughs, Hendon, London, UK NW4 4BT
Academic
qualification: 2017-2020
MPhil/PhD in Biomedical Science Middlesex
University, Department of Natural Sciences, Faculty of Science & Technology,
London: UK Thesis:
Induction of death in myeloid leukaemia
cells by doxorubicin and betulinic acid, singly and in combination was
associated with the regulation of apoptosis, autophagy and the PI3K/Akt
pathways 2012-2015
BSc
(First class honours) in Biomedical Science (Full-time) Middlesex
University, Department of Natural Sciences, Faculty of Science & Technology,
London: UK Dissertation:
Evaluation of the anti-proliferative and apoptotic effect of betulinic acid and
doxorubicin on acute leukaemia cell lines
Awarded for final year project
(Middlesex University) - Ellis Snitcher Memorial Prize for Integrative Medicine
Teaching
Employment
Education and qualifications
Middlesex University, Department of Natural Sciences, Faculty of Science & Technology, London: UK
Thesis: Induction of death in myeloid leukaemia cells by doxorubicin and betulinic acid, singly and in combination was associated with the regulation of apoptosis, autophagy and the PI3K/Akt pathways
Middlesex University, Department of Natural Sciences, Faculty of Science & Technology, London: UK
Dissertation: Evaluation of the anti-proliferative and apoptotic effect of betulinic acid and doxorubicin on acute leukaemia cell lines
Awarded for final year project (Middlesex University) - Ellis Snitcher Memorial Prize for Integrative Medicine
Prizes and Awards
Ellis Snitcher Memorial Prize for Integrative Medicine
2015-06-29
Middlesex University
RSSC: The best oral presentation
2018-09-04
Middlesex University
Research outputs
Wastewater monitoring for detection of public health markers during the COVID-19 pandemic: Near-source monitoring of schools in England over an academic year
Hassard, F., Vu, M., Rahimzadeh, S., Castro-Gutierrez, V., Stanton, I., Burczynska, B., Wildeboer, D., Baio, G., Brown, M., Garelick, H., Hofman, J., Kasprzyk-Hordern, B., Majeed, A., Priest, S., Denise, H., Khalifa, M., Bassano, I., Wade, M., Grimsley, J., Lundy, L., Singer, A. and Di Cesare, M. 2023. Wastewater monitoring for detection of public health markers during the COVID-19 pandemic: Near-source monitoring of schools in England over an academic year. PLoS ONE. 18 (5). https://doi.org/10.1371/journal.pone.0286259Induction of death in myeloid leukaemia cells by doxorubicin and betulinic acid, singly and in combination was associated with the regulation of apoptosis, autophagy and the PI3K/Akt pathways
Vu, M. 2020. Induction of death in myeloid leukaemia cells by doxorubicin and betulinic acid, singly and in combination was associated with the regulation of apoptosis, autophagy and the PI3K/Akt pathways. PhD thesis Middlesex University Science and TechnologyMonitoring occurrence of SARS-CoV-2 in school populations: A wastewater-based approach
Castro-Gutierrez, V., Hassard, F., Vu, M., Leitao, R., Burczynska, B., Wildeboer, D., Stanton, I., Rahimzadeh, S., Baio, G., Garelick, H., Hofman, J., Kasprzyk-Hordern, B., Kwiatkowska, R., Majeed, A., Priest, S., Grimsley, J., Lundy, L., Singer, A. and Di Cesare, M. 2022. Monitoring occurrence of SARS-CoV-2 in school populations: A wastewater-based approach. PLoS ONE. 17 (6). https://doi.org/10.1371/journal.pone.0270168Betulinic Acid–Doxorubicin-Drug combination induced apoptotic death via ROS stimulation in a relapsed AML MOLM-13 cell model
Vu, M., Kassouf, N. and Appiah, S. 2021. Betulinic Acid–Doxorubicin-Drug combination induced apoptotic death via ROS stimulation in a relapsed AML MOLM-13 cell model. Antioxidants. 10 (9). https://doi.org/10.3390/antiox10091456Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl‑2 in acute myeloid leukaemia MOLM‑13 cells with reduced Beclin 1 expression
Vu, M., Kassouf, N., Ofili, R., Lund, T., Bell, C. and Appiah, S. 2020. Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl‑2 in acute myeloid leukaemia MOLM‑13 cells with reduced Beclin 1 expression. International Journal of Oncology. 57 (1), pp. 113-121. https://doi.org/10.3892/ijo.2020.5052Betulinic acid-doxorubicin drug combination synergistically supresses cell viability and enhances apoptotic death in acute myeloid leukaemia cell lines by increasing Bax/Bcl-2 ratio
Vu, M., Kassouf, N., Bell, C. and Appiah, S. 2018. Betulinic acid-doxorubicin drug combination synergistically supresses cell viability and enhances apoptotic death in acute myeloid leukaemia cell lines by increasing Bax/Bcl-2 ratio. NCRI Cancer Conference (2018). Glasgow, Scotland 04 - 06 Nov 2018Evaluation of the effectiveness of Eladi Keram for the treatment of acne vulgaris: a randomised controlled pilot study
Appiah, S., Lawley, B., Vu, M., Bell, C. and Jones, H. 2017. Evaluation of the effectiveness of Eladi Keram for the treatment of acne vulgaris: a randomised controlled pilot study. European Journal of Integrative Medicine. 12, pp. 38-43. https://doi.org/10.1016/j.eujim.2017.04.004Antiinflammatory and hepatoprotective medicinal herbs as potential substitutes for bear bile
Appiah, S., Revitt, D., Jones, H., Vu, M., Simmonds, M. and Bell, C. 2017. Antiinflammatory and hepatoprotective medicinal herbs as potential substitutes for bear bile. in: Zeng, B. and Zhao, K. (ed.) Neurobiology of Chinese Herb Medicine Elsevier.572
total views of outputs80
total downloads of outputs8
views of outputs this month0
downloads of outputs this month